Table 1.
General characteristics of women undergoing ART (N = 60)
Socio-demographic Data (N = 60) | Health Status and Lifestyle (N = 60) | Reproduction (N = 60) | Medical records by IVF/ICSI (N = 45) | ||||
---|---|---|---|---|---|---|---|
Age (years) | BMI (kg/m2) | Indication (Self-report) | N (%) | Indication | |||
Mean (SD) | 34.6 (±5.2) | Mean (SD) | 24.2 (±4.9) | Female | 26 (43.3) | Poor semen quality | 11 (24.4%) |
Education | Underweight (< 18.5) | 5 (8.3%) | Male | 4 (6.7) | Fallopian tube | 11 (24.4%) | |
2003Low | 6 (10.0%) | Normal weight (18.5–24.9) | 37 (61.7%) | Dual | 14 (23.3) | Endometriosis | 7 (15.6%) |
Intermediate | 18 (30.0%) | Overweight (25–29.9) | 7 (11.7%) | Undefined | 13 (21.7) | Other female | 4 (8.9%) |
High | 36 (60.0%) | Obesity (> 30) | 11 (18.3%) | Diagnosis in progress | 3 (5.0) | Unexplained | 12 (25.6%) |
Marital status (N = 44) | Self-Rated Physical Health | Type of ART Treatment | Procedures | ||||
Married | 47 (78.3%) | Poor | 0 | IVF/ICSI | 50 (82.3) | Cycle 1 | 11 (24.4%) |
Partner | 13 (21.7%) | Fair | 1 (1.7%) | IUI | 1 (2.1) | Cycle 2 | 16 (35.6%) |
Place of residence | Neither good nor bad | 13 (21.7%) | OI | 2 (4.2) | Cycle 3 | 12 (26.7) | |
County seat | 18 (30.0%) | Good | 37 (61.7%) | HSG | 2 (4.2) | Cycle 4 | 6 (13.3%) |
City | 27 (45.0%) | Excellent | 9 (15.0%) | Examination in progress | 5 (31.1) | Serum oestradiol - pmol/l | 1692 ± 2073 |
Village | 15 (25.0%) | Healthy Diet | Child-wish (months) | Mean ± SD | Progesterone - nmol/l | 30.42 ± 21.29 | |
Income | Pay attention | 56 (93.3%) | Mean (SD) | 59.0 ± 38.4 | FSHa - IU | 2493 ± 2925 | |
Low | 2 (3.3%) | Not really / No attention | 4 (6.7%) | Relationship (years) | Gonadotropina - IU | 0.86 ± 0.19 | |
Medium | 34 (56.6%) | Tobacco Use | Mean (SD) | 7.6 ± 3.8 | No. of oocytes | 7.87 ± 4.96 | |
High | 24 (40.0%) | Occasional | 2 (3.3%) | Gravidity (N = 45) | N (%) | No. of matured oocytesb | 5.44 ± 3.93 |
Non-Smoker | 58 (96.7%) | Nulligravid | 25 (55.6) | No. of Grade 1 embryos | 3.31 ± 2.98 | ||
Exercise | Multigravid | 20 (44.4) | No of transferred embryos | 1.46 ± 0.84 | |||
Regularly 4–7 days weekly | 6 (10.0%) | Parity(N = 45) | hCG on day 12 - IU | 364.9 ± 912.3 | |||
Regularly1–3 days weekly | 24 (40.0%) | Nulliparous | 38 (84.4) | Chemical pregnancies | 22 (48.89%) | ||
Not | 30 (50.0) | Multiparous | 7 (15.6) | Clinical pregnancies | 13 (28.9%) |
ART Assisted Reproductive Therapy, BMI Body Mass Index, HSG Hysterosalpingogram, ICSI Intracytoplasmic Sperm Injection, IUI Intrauterine Insemination, IVF In-Vitro Fertilization, OI Ovulation Induction, a: Total dose administrated, b Metaphase II).